282 related articles for article (PubMed ID: 37982994)
1. Underlying Mechanisms and Treatment of Hypertension in Glomerular Diseases.
Koubar SH; Garcia-Rivera A; Mohamed MMB; Hall JE; Hall ME; Hassanein M
Curr Hypertens Rep; 2024 Mar; 26(3):119-130. PubMed ID: 37982994
[TBL] [Abstract][Full Text] [Related]
2. Hypertension and kidneys: unraveling complex molecular mechanisms underlying hypertensive renal damage.
Mennuni S; Rubattu S; Pierelli G; Tocci G; Fofi C; Volpe M
J Hum Hypertens; 2014 Feb; 28(2):74-9. PubMed ID: 23803592
[TBL] [Abstract][Full Text] [Related]
3. [Are all antihypertensive drugs renoprotective?].
Wolf S; Risler T
Herz; 2004 May; 29(3):248-54. PubMed ID: 15167950
[TBL] [Abstract][Full Text] [Related]
4. Questioning the renoprotective role of L-type calcium channel blockers in chronic kidney disease using physiological modeling.
Moore KH; Clemmer JS
Am J Physiol Renal Physiol; 2021 Oct; 321(4):F548-F557. PubMed ID: 34486399
[TBL] [Abstract][Full Text] [Related]
5. [Does the rennin inhibitor aliskiren offer promising novel opportunities in the treatment of cardiovascular diseases?].
Horký K
Vnitr Lek; 2007 Apr; 53(4):364-70. PubMed ID: 17578167
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of Cardiovascular Disease Risk Factors in Childhood Glomerular Diseases.
Ashoor IF; Mansfield SA; O'Shaughnessy MM; Parekh RS; Zee J; Vasylyeva TL; Kogon AJ; Sethna CB; Glenn DA; Chishti AS; Weaver DJ; Helmuth ME; Fernandez HE; Rheault MN;
J Am Heart Assoc; 2019 Jul; 8(14):e012143. PubMed ID: 31286821
[TBL] [Abstract][Full Text] [Related]
7. [Slowing the progression of chronic renal insufficiency with captopril in rats with spontaneous arterial hypertension and adriamycin nephropathy].
Jovanović DB; Jovović Dj; Varagić J; Dimitrijević J; Dragojlović Z; Djukanović L
Srp Arh Celok Lek; 2002; 130(3-4):73-80. PubMed ID: 12154518
[TBL] [Abstract][Full Text] [Related]
8. The role of arterial hypertension in the progression of non-diabetic glomerular diseases.
Ljutić D; Kes P
Nephrol Dial Transplant; 2003 Jul; 18 Suppl 5():v28-30. PubMed ID: 12817064
[TBL] [Abstract][Full Text] [Related]
9. A model-based approach to investigating the pathophysiological mechanisms of hypertension and response to antihypertensive therapies: extending the Guyton model.
Hallow KM; Lo A; Beh J; Rodrigo M; Ermakov S; Friedman S; de Leon H; Sarkar A; Xiong Y; Sarangapani R; Schmidt H; Webb R; Kondic AG
Am J Physiol Regul Integr Comp Physiol; 2014 May; 306(9):R647-62. PubMed ID: 24500431
[TBL] [Abstract][Full Text] [Related]
10. The Role of Immunosuppressive Medications in the Pathogenesis of Hypertension and Efficacy and Safety of Antihypertensive Agents in Kidney Transplant Recipients.
Divac N; Naumović R; Stojanović R; Prostran M
Curr Med Chem; 2016; 23(19):1941-52. PubMed ID: 26687832
[TBL] [Abstract][Full Text] [Related]
11. [Treatment of hypertension in renal parenchymal diseases].
Iversen BM; Kvam FI; Svarstad E
Tidsskr Nor Laegeforen; 1996 Jun; 116(17):2022-6. PubMed ID: 8766645
[TBL] [Abstract][Full Text] [Related]
12. Direct renin inhibition: from pharmacological innovation to novel therapeutic opportunities.
Volpe M; Pontremoli R; Borghi C
High Blood Press Cardiovasc Prev; 2011 Sep; 18(3):93-105. PubMed ID: 21950781
[TBL] [Abstract][Full Text] [Related]
13. Subclinical Kidney Damage in Hypertensive Patients: A Renal Window Opened on the Cardiovascular System. Focus on Microalbuminuria.
Mulè G; Castiglia A; Cusumano C; Scaduto E; Geraci G; Altieri D; Di Natale E; Cacciatore O; Cerasola G; Cottone S
Adv Exp Med Biol; 2017; 956():279-306. PubMed ID: 27873229
[TBL] [Abstract][Full Text] [Related]
14. Angiotensin receptor blockers: RAAS blockade and renoprotection.
Ruilope LM
Curr Med Res Opin; 2008 May; 24(5):1285-93. PubMed ID: 18366863
[TBL] [Abstract][Full Text] [Related]
15. What have we learned from the current trials?
Abbott KC; Bakris GL
Med Clin North Am; 2004 Jan; 88(1):189-207. PubMed ID: 14871059
[TBL] [Abstract][Full Text] [Related]
16. Hypertension after kidney transplantation: impact, pathogenesis and therapy.
Zhang R; Leslie B; Boudreaux JP; Frey D; Reisin E
Am J Med Sci; 2003 Apr; 325(4):202-8. PubMed ID: 12695725
[TBL] [Abstract][Full Text] [Related]
17. Non-immunosuppressive treatment for IgA nephropathy.
Tunnicliffe DJ; Reid S; Craig JC; Samuels JA; Molony DA; Strippoli GF
Cochrane Database Syst Rev; 2024 Feb; 2(2):CD003962. PubMed ID: 38299639
[TBL] [Abstract][Full Text] [Related]
18. Angiotensin receptor blockers in hypertension and cardiovascular diseases.
de la Sierra A
Cardiovasc Hematol Agents Med Chem; 2006 Jan; 4(1):67-73. PubMed ID: 16529551
[TBL] [Abstract][Full Text] [Related]
19. Newer Drugs to Reduce High Blood Pressure and Mitigate Hypertensive Target Organ Damage.
Upadhya B; Kozak PM; Stacey RB; Vasan RS
Curr Hypertens Rep; 2022 Jan; 24(1):1-20. PubMed ID: 35165832
[TBL] [Abstract][Full Text] [Related]
20. [Hypertension and the kidney].
Hohenstein K; Watschinger B
Wien Med Wochenschr; 2008; 158(13-14):359-64. PubMed ID: 18677585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
